Emerging role of mucins in antibody drug conjugates for ovarian cancer therapy

• Egile Nagusiak: Shabnam Malik (Egilea), Mohammed Sikander (Egilea), Natasha Bell (Egilea), Daniel Zubieta (Egilea), Maria C. Bell (Egilea), Murali M. Yallapu (Egilea), Subhash C. Chauhan (Egilea)
• Formatua: Liburua
• Argitaratua: BMC, 2024-08-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract Ovarian cancer stands as the deadliest gynecologic malignancy, responsible for nearly 65% of all gynecologic cancer-related deaths. The challenges in early detection and diagnosis, coupled with the widespread intraperitoneal spread of cancer cells and resistance to chemotherapy, contribute...